Commentary on “Comparative effectiveness of axitinib vs. sorafenib in advanced renal cell carcinoma (AXIS): A randomized phase 3 trial.” B.I. Rini, B. Escudier, P. Tomczak, A. Kaprin, C. Szczylik, T.E. Hutson, M.D. Michaelson, V.A. Gorbunova, M.E. Gore, I.G. Rusakov, S. Negrier, Y.C. Ou, D. Castellano, H.Y. Lim, H. Uemura, J. Tarazi, D. Cella, C. Chen, B. Rosbrook, S. Kim, R.J. Motzer

✍ Scribed by Trump, Donald L.

• Book ID: 118503121
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 66 KB
• Volume: 30
• Category: Article
• ISSN: 1078-1439
• DOI: 10.1016/j.urolonc.2012.06.009